col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


48 Results       Page 1

 [1] 
Oxford University Press: JAC-Antimicrobial Resistance
  original article Date Title Authors   All Authors
1 [GO] 2025―Dec―04 P97 Bacterial and fungal secondary infections in COVID-19 patients following immunomodulatory therapy: England, January 2020 to August 2023 Chloe Davison, Russell Hope, Colin S Brown, Lance Turtle, Antonia Ho, Sarah M Gerver
2 [GO] 2025―Dec―04 P14 Multidisciplinary antimicrobial stewardship: transforming COVID-19 pandemic response and combating global antimicrobial resistance in UK healthcare settings Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
3 [GO] 2025―Nov―09 Molecular detection of carbapenemases in critical microorganisms since the onset of the COVID-19 pandemic in Peru Maritza Mayta-Barrios, Juan Ramírez-Illescas, Juan Pacori, Joshi Acosta, Luis Pampa-Espinoza, Javier Silva-Valencia, et al. (+87)
4 [GO] 2025―Oct―08 Association between SARS-CoV-2 testing and antibiotic use in Swiss long-term care facilities: a retrospective multicentric study Marc Jeanneret, Alexia Roux, Isabella Locatelli, Alessandro Cassini, Emmanouil Glampedakis, Anne Niquille, Noémie Boillat-Blanco
5 [GO] 2025―Jul―17 Trends in antibiotic dispensing for children in Belgian ambulatory care: time series analysis before, during, and after the COVID-19 pandemic Hannelore Dillen, Axelle Van de Velde, Chloë Withofs, Laure Wynants, Jan Y Verbakel
6 [GO] 2025―Jul―14 P55 The impact of vitamin D deficiency on COVID-19 severity in the UK: a systematic literature review Riya Ann Moncy, Rasha Abdelsalam Elshenawy
7 [GO] 2025―Jul―14 P15 From pandemic to policy: leveraging COVID-19 lessons to strengthen antimicrobial stewardship Rasha Abdelsalam Elshenawy
8 [GO] 2025―Apr―24 P25. Characteristics, treatment options, and predictors of clinical failure among Pseudomonas aeruginosa infection with microbiologically confirmed intermediate or resistant carbapenem susceptibility profile: a multicenter clinical experience on behalf of CASPER (CArbapenem-reSistant Pseudomonas aERuginosa during and after the COVID-19 pandemic) study group A Dessilani, S Kaleci, G Orlando, M Del Monte, A Bedini, E Franceschini, et al. (+14)
9 [GO] 2025―Mar―14 Patterns of antibiotic resistance in urinary tract infections before and during the COVID-19 pandemic in Uganda and Tanzania Vitus Silago, Katherine Keenan, Martha F Mushi, Catherine Kansiime, Benon Asiimwe, Benjamin Sunday, et al. (+31)
10 [GO] 2025―Feb―28 The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study Refath Farzana, Stephan Jürgen Harbarth, Ly-Mee Yu, Edoardo Carretto, Catrin E Moore, Nicholas Alexander Feasey, et al. (+82)
11 [GO] 2025―Jan―24 Global prevalence of human intestinal carriage of ESBL-producing E. coli during and after the COVID-19 pandemic Rita W Y Ng, Liuyue Yang, Sai Hung Lau, Peter Hawkey, Margaret Ip
12 [GO] 2025―Jan―23 P01 Cluster randomized controlled trial (RCT) of Air Filtration to prevent Respiratory Infections (including COVID-19) in care homes: the AFRI-c trial Alastair Hay, Rachel Brierley, Nick Turner, Joanna Thorn, Sophie Rees, Jodi Taylor, et al. (+11)
13 [GO] 2024―Dec―12 The impact of the COVID-19 pandemic on the antimicrobial stewardship workforce in Scottish acute care hospitals-a qualitative study Ayodeji Matuluko, Valerie Ness, Jennifer Macdonald, Jacqueline Sneddon, Ronald Andrew Seaton, Kay Currie
14 [GO] 2024―Aug―23 O04 UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
15 [GO] 2024―Aug―23 P11 Pharmacists’ knowledge, attitudes and perceptions towards antimicrobial stewardship and resistance during the COVID-19 pandemic at secondary care settings in the UK Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
16 [GO] 2024―Aug―08 COVID-19 restrictions limited interactions of people and resulted in lowered E. coli antimicrobial resistance rates Peter Collignon, John Beggs, Jennifer Robson
17 [GO] 2024―Jun―11 Antibiotic prescribing and bacterial infection in COVID-19 inpatients in Southeast Asia: a systematic review and meta-analysis Achiraya Chanapal, Hung-Yung Cheng, Helen Lambert, Wenjuan Cong
18 [GO] 2024―May―27 Antibiotic utilization patterns in Tanzania: a retrospective longitudinal study comparing pre- and intra-COVID-19 pandemic era using Tanzania Medicines and Medical Devices Authority data Raphael Z Sangeda, Sahani M William, Faustine C Masatu, Adonis Bitegeko, Yonah H Mwalwisi, Emmanuel A Nkiligi, et al. (+2)
19 [GO] 2024―Apr―24 Comparing indicators of disease severity among patients presenting to hospital for urinary tract infections before and during the COVID-19 pandemic Selina Patel, Martin Gill, Andrew Hayward, Susan Hopkins, Andrew Copas, Laura Shallcross
20 [GO] 2024―Feb―22 Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications Steward Mudenda, Robert Chilimboyi, Scott Kaba Matafwali, Victor Daka, Ruth Lindizyani Mfune, Loriane Arielle Mobou Kemgne, et al. (+5)
21 [GO] 2024―Feb―07 Should we stop referring to the pandemic of antimicrobial resistance as silent? Miroslav Sirota
22 [GO] 2024―Feb―07 Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis Sidra Khan, Stuart E Bond, Jade Lee-Milner, Barbara R Conway, William J Lattyak, Mamoon A Aldeyab
23 [GO] 2023―Nov―13 Antimicrobial prescribing in a secondary care setting during the COVID-19 pandemic Michael M Tadros, Marian S Boshra, Michael Scott, Glenda Fleming, Fidelma Magee, Mohammad I Hamed, et al. (+4)
24 [GO] 2023―Aug―02 P16 COVID-19 and urinary tract infection: the main manifestations and their management Kiarina Chichirelo-Konstantynovych, Tetyana Konstantynovych
25 [GO] 2023―Aug―02 P15 Women’s satisfaction with the management of urinary tract infections during the COVID-19 pandemic: a qualitative analysis of free-text comments from a national survey in England A’mar Dababneh, Leigh Sanyaolu, Haroon Ahmed, Dushyanthi Alagiyawanna, Donna Lecky, Emily Cooper
26 [GO] 2023―Jul―17 The impact of COVID-19 national restrictions on dental antibiotic dispensing trends and treatment activity in England: January 2016 to July 2021 Angela Falola, Alicia Demirjian, Wendy Thompson, Colin S Brown, Sarah Gerver, Sabine Bou-Antoun
27 [GO] 2023―Jun―14 P17 Aetiology of hospital-acquired Gram-negative bacteraemias over the COVID-19 pandemic: a single NHS Trust experience, UK Syra Dhillon, Oscar Buchanan, Catherine Sargent
28 [GO] 2023―Jun―09 Knowledge, attitude and practice of healthcare workers towards antibiotic resistance during the COVID-19 pandemic Hadi Al Sulayyim, Rohani Ismail, Abdullah Al Hamid, Noraini Abdul Ghafar
29 [GO] 2023―Feb―11 Sustained increases in antibiotic prescriptions per primary care consultation for upper respiratory tract infections in England during the COVID-19 pandemic Zheyuan Yang, Sabine Bou-Antoun, Sarah Gerver, Thomas E Cowling, Rachel Freeman
30 [GO] 2023―Jan―19 P16 Overuse of antibiotics during the first year of the COVID-19 pandemic in Poland Izabella Owsianka, Mateusz Gajda, Paweł Krzyściak, Barbara Gryglewska, Anna Różańska, Jadwiga Wójkowska-Mach
31 [GO] 2022―Dec―13 A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era Valerie Leung, Jacquelyn Quirk, Sarah Muir, Nick Daneman, Kevin L Schwartz, Bradley J Langford
32 [GO] 2022―Dec―07 The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review Lucy S Witt, Jessica R Howard-Anderson, Jesse T Jacob, Lindsey B Gottlieb
33 [GO] 2022―Jun―16 Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Valentina Galfo, Sara Occhineri, Stefano Verdenelli, et al. (+23)
34 [GO] 2022―Jun―01 P12 Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in Wave 1 versus Wave 2: a systematic review Saif Abbas Chatoo, Emma Thomas-Jones, Philip Pallmann, Joanne Euden
35 [GO] 2022―Jun―01 P05 The impact of COVID-19 on antifungal stewardship in a UK tertiary teaching hospital: a review of prescribing practices and therapeutic drug monitoring of posaconazole Adam Andreani, Netta Tyler, Christiane Micallef, David Enoch, Vanessa Wong
36 [GO] 2022―Mar―16 Antibiotic resistance: calling time on the ‘silent pandemic’ Marc Mendelson, Michael Sharland, Mirfin Mpundu
37 [GO] 2022―Feb―16 P36 Procalcitonin as an antimicrobial stewardship tool in the COVID-19 era: a single centre experience Margaret Creedon, Alida Fe Talento, Roisin Connolly, Aine Egan, Tidi Hassan, Marta Trzos-Grzybowksa
38 [GO] 2022―Feb―16 P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study Joanne Euden, Philip Howard, Neil Powell, Martin J. Llewelyn, Tamas Szakmany, Mahableswhar Albur, et al. (+17)
39 [GO] 2022―Feb―16 O03 The impact of COVID-19 infection prevention and control measures on transmission of hospital-acquired infections and antimicrobial resistance in Africa Linzy Elton, Muzamil M. Abdel Hamid, John Tembo, Hana Elbadawi, Kwitaka Maluzi, Mohamed H. Abdelraheem, et al. (+5)
40 [GO] 2022―Feb―16 P12 Important early prognostic laboratory indicators for COVID-19 mortality Ergys Ramosaço, Entela Kolovani, Nevila Gjermeni, Najada Çomo
41 [GO] 2022―Feb―16 P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship Lois Hawkins, Ting Yau, Tihana Bicanic, Marina Basarab
42 [GO] 2022―Feb―16 P27 Bacterial coinfection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis Maria Calderon, Grace Gysin, Sarah Walpole, Felicity Mills, Daniel Comandé, Ewan Hunter
43 [GO] 2022―Feb―16 P30 Bacterial coinfection and prescribing trends in SARS-CoV-2 infection in two UK hospitals P. J. Teoh, I. Maan, J. Uwagwu, A. Odedra
44 [GO] 2021―Sep―07 Educational Resource Review: MSD’s The Steward-Episode 6-The impact of COVID-19 on AMS
45 [GO] 2021―Aug―28 Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja® (cefiderocol) in UK clinical practice: introduction; Antibiotic resistance during and beyond COVID-19; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’
46 [GO] 2021―Mar―01 Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective Deepa Dahal, Swarna Sundar, Ravina Kullar, Neda Milevska-Kostova, Karen Dindial
47 [GO] 2020―Dec―09 Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection Liam Townsend, Gerry Hughes, Colm Kerr, Mary Kelly, Roisin O’Connor, Eileen Sweeney, et al. (+5)
48 [GO] 2020―Apr―08 Infection prevention and control (IPC) for novel coronavirus (COVID-19)
 [1] 

48 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.027 sec